{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:14:00Z","timestamp":1767856440057,"version":"3.49.0"},"reference-count":53,"publisher":"Impact Journals, LLC","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2022,9,29]]},"DOI":"10.18632\/aging.204299","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T01:05:00Z","timestamp":1663808700000},"page":"7193-7205","source":"Crossref","is-referenced-by-count":5,"title":["Humoral immunoresponse elicited against an adenoviral-based SARS-CoV-2 coronavirus vaccine in elderly patients"],"prefix":"10.18632","volume":"14","author":[{"given":"Rodrigo Hern\u00e1n","family":"Tomas-Grau","sequence":"first","affiliation":[{"name":"Instituto de Investigaci\u00f3n en Medicina Molecular y Celular Aplicada - IMMCA (UNT-CONICET-SIPROSA), Tucum\u00e1n 4000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Maldonado-Galdeano","sequence":"additional","affiliation":[{"name":"Centro de Referencia para Lactobacilos \u2013 CERELA (CONICET), Tucum\u00e1n 4000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica Aguilar","family":"L\u00f3pez","sequence":"additional","affiliation":[{"name":"Public Healthcare Administration (SIPROSA), Tucum\u00e1n 4000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban Vera","family":"Pingitore","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n en Medicina Molecular y Celular Aplicada - IMMCA (UNT-CONICET-SIPROSA), Tucum\u00e1n 4000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Aznar","sequence":"additional","affiliation":[{"name":"N\u00e9stor Kirchner Hospital, Central Public Health laboratory (LSP) (SIPROSA), Tucum\u00e1n 4000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Elena","family":"Alcorta","sequence":"additional","affiliation":[{"name":"N\u00e9stor Kirchner Hospital, Central Public Health laboratory (LSP) (SIPROSA), Tucum\u00e1n 4000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva Mar\u00eda","family":"del Mar V\u00e9lez","sequence":"additional","affiliation":[{"name":"N\u00e9stor Kirchner Hospital, Central Public Health laboratory (LSP) (SIPROSA), Tucum\u00e1n 4000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agust\u00edn","family":"Stagnetto","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n en Medicina Molecular y Celular Aplicada - IMMCA (UNT-CONICET-SIPROSA), Tucum\u00e1n 4000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana Estefan\u00eda","family":"Soliz-Santander","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n en Medicina Molecular y Celular Aplicada - IMMCA (UNT-CONICET-SIPROSA), Tucum\u00e1n 4000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9sar Lu\u00eds","family":"\u00c1vila","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n en Medicina Molecular y Celular Aplicada - IMMCA (UNT-CONICET-SIPROSA), Tucum\u00e1n 4000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio Benjam\u00edn","family":"Socias","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n en Medicina Molecular y Celular Aplicada - IMMCA (UNT-CONICET-SIPROSA), Tucum\u00e1n 4000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dardo","family":"Costas","sequence":"additional","affiliation":[{"name":"N\u00e9stor Kirchner Hospital, Central Public Health laboratory (LSP) (SIPROSA), Tucum\u00e1n 4000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossana Elena","family":"Chahla","sequence":"additional","affiliation":[{"name":"Public Healthcare Administration (SIPROSA), Tucum\u00e1n 4000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Perdig\u00f3n","sequence":"additional","affiliation":[{"name":"Centro de Referencia para Lactobacilos \u2013 CERELA (CONICET), Tucum\u00e1n 4000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosana Nieves","family":"Cheh\u00edn","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n en Medicina Molecular y Celular Aplicada - IMMCA (UNT-CONICET-SIPROSA), Tucum\u00e1n 4000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Ploper","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n en Medicina Molecular y Celular Aplicada - IMMCA (UNT-CONICET-SIPROSA), Tucum\u00e1n 4000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia In\u00e9s","family":"Cazorla","sequence":"additional","affiliation":[{"name":"Centro de Referencia para Lactobacilos \u2013 CERELA (CONICET), Tucum\u00e1n 4000, Argentina"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2022,9,21]]},"reference":[{"key":"1","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard. https:\/\/covid19.who.int."},{"key":"2","doi-asserted-by":"publisher","first-page":"101205","DOI":"10.1016\/j.arr.2020.101205","article-title":"Aging in COVID-19: Vulnerability, immunity and intervention.","volume":"6","author":"Leng","year":"2021","journal-title":"Ageing Res Rev"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08899-6","article-title":"Immunology of Aging: the Birth of Inflammaging.","author":"Franceschi","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"4","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1056\/NEJMp2006761","article-title":"Covid-19 and Immunity in Aging Populations - A New Research Agenda.","volume":"38","author":"Williams","year":"2020","journal-title":"N Engl J Med"},{"key":"5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.it.2004.05.006","article-title":"Is immunosenescence infectious?","volume":"2","author":"Wikby","year":"2004","journal-title":"Trends Immunol"},{"key":"6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/ciia.2007.2.1.33","article-title":"Immunosupportive therapies in aging.","volume":"2","author":"Pawelec","year":"2007","journal-title":"Clin Interv Aging"},{"key":"7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11357-016-9919-9","article-title":"Increased levels of hyper-stable protein aggregates in plasma of older adults.","volume":"3","author":"Col\u00f3n","year":"2016","journal-title":"Age (Dordr)"},{"key":"8","doi-asserted-by":"publisher","first-page":"12539","DOI":"10.3390\/ijms222212539","article-title":"How Immunosenescence and Inflammaging May Contribute to Hyperinflammatory Syndrome in COVID-19.","volume":"2","author":"Di Benedetto","year":"2021","journal-title":"Int J Mol Sci"},{"key":"9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.semcancer.2011.09.001","article-title":"Cellular senescence: a link between cancer and age-related degenerative disease?","volume":"2","author":"Melov","year":"2011","journal-title":"Semin Cancer Biol"},{"key":"10","doi-asserted-by":"publisher","first-page":"775224","DOI":"10.3389\/fpubh.2021.775224","article-title":"The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern.","volume":"9","author":"He","year":"2021","journal-title":"Front Public Health"},{"key":"11","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1111\/all.14429","article-title":"Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors.","volume":"7","author":"Lunjani","year":"2020","journal-title":"Allergy"},{"key":"12","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development.","volume":"58","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"13","doi-asserted-by":"publisher","first-page":"602256","DOI":"10.3389\/fimmu.2020.602256","article-title":"COVID-19: Coronavirus Vaccine Development Updates.","volume":"1","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"14","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.2174\/0929867328666210902094254","article-title":"The Impact of Vaccination Worldwide on SARS-CoV-2 Infection: A Review on Vaccine Mechanisms, Results of Clinical Trials, Vaccinal Coverage and Interactions with Novel Variants.","volume":"2","author":"Sim\u00f5es E Silva","year":"2022","journal-title":"Curr Med Chem"},{"key":"15","doi-asserted-by":"publisher","first-page":"101468","DOI":"10.1016\/j.eclinm.2022.101468","article-title":"ROCCA cohort study: Nationwide results on safety of Gam-COVID-Vac vaccine (Sputnik V) in the Republic of San Marino using active surveillance.","volume":"4","author":"Gori","year":"2022","journal-title":"EClinicalMedicine"},{"key":"16","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1056\/NEJMoa2110362","article-title":"Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings.","volume":"38","author":"Birch","year":"2021","journal-title":"N Engl J Med"},{"key":"17","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1007\/s00281-020-00821-0","article-title":"Shelter from the cytokine storm: pitfalls and prospects in the development of SARS-CoV-2 vaccines for an elderly population.","volume":"4","author":"Medaglini","year":"2020","journal-title":"Semin Immunopathol"},{"key":"18","doi-asserted-by":"publisher","first-page":"720988","DOI":"10.3389\/fmed.2021.720988","article-title":"Elevated Humoral Immune Response to SARS-CoV-2 at High Altitudes Revealed by an Anti-RBD \"\" ELISA.","volume":"8","author":"Aznar","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"19","doi-asserted-by":"publisher","first-page":"100123","DOI":"10.1016\/j.lana.2021.100123","article-title":"Long-term analysis of antibodies elicited by SPUTNIK V: A prospective cohort study in Tucum\u00e1n, Argentina.","volume":"6","author":"Socias","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"20","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1126\/science.abm8108","article-title":"The immunology and immunopathology of COVID-19.","volume":"37","author":"Iwasaki","year":"2022","journal-title":"Science"},{"key":"21","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00391-021-01864-0","article-title":"[COVID-19 in old age-The geriatric perspective].","volume":"5","author":"Bauer","year":"2021","journal-title":"Z Gerontol Geriatr"},{"key":"22","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.","volume":"39","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"23","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/ageing\/afaa274","article-title":"Efficacy and safety of COVID-19 vaccines in older people.","volume":"5","author":"Thomson","year":"2021","journal-title":"Age Ageing"},{"key":"24","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ijid.2021.07.070","article-title":"Immunoglobulin G antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals may need just one vaccine dose.","volume":"11","author":"de Waard","year":"2021","journal-title":"Int J Infect Dis"},{"key":"25","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/S0140-6736(21)00502-X","article-title":"Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine.","volume":"39","author":"Willicombe","year":"2021","journal-title":"Lancet"},{"key":"26","doi-asserted-by":"publisher","first-page":"100359","DOI":"10.1016\/j.xcrm.2021.100359","article-title":"Sputnik V vaccine elicits seroconversion and neutralizing capacity to SARS-CoV-2 after a single dose.","volume":"2","author":"Wenker","year":"2021","journal-title":"Cell Rep Med"},{"key":"27","doi-asserted-by":"publisher","first-page":"e0344221","DOI":"10.1128\/mbio.03442-21","article-title":"Longitudinal Study after Sputnik V Vaccination Shows Durable SARS-CoV-2 Neutralizing Antibodies and Reduced Viral Variant Escape to Neutralization over Time.","volume":"1","author":"Caramelo","year":"2022","journal-title":"mBio"},{"key":"28","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.cmi.2022.03.003","article-title":"Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study.","volume":"2","author":"Klastrup","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"29","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41467-020-14396-9","article-title":"Sexual-dimorphism in human immune system aging.","volume":"1","author":"Ucar","year":"2020","journal-title":"Nat Commun"},{"key":"30","doi-asserted-by":"publisher","first-page":"e0266958","DOI":"10.1371\/journal.pone.0266958","article-title":"Age and sex associations of SARS-CoV-2 antibody responses post BNT162b2 vaccination in healthcare workers: A mixed effects model across two vaccination periods.","volume":"1","author":"Tsakris","year":"2022","journal-title":"PLoS One"},{"key":"31","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1017\/S1049023X20000837","article-title":"An Insight into the Sex Differences in COVID-19 Patients: What are the Possible Causes?","volume":"3","author":"Momen-Heravi","year":"2020","journal-title":"Prehosp Disaster Med"},{"key":"32","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","article-title":"Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults.","volume":"38","author":"Lin","year":"2020","journal-title":"N Engl J Med"},{"key":"33","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates.","volume":"38","author":"Koury","year":"2020","journal-title":"N Engl J Med"},{"key":"34","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0140-6736(20)31605-6","article-title":"Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.","volume":"39","author":"Wu","year":"2020","journal-title":"Lancet"},{"key":"35","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1016\/S0140-6736(20)32466-1","article-title":"Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2\/3 trial.","volume":"39","author":"Bibi","year":"2021","journal-title":"Lancet"},{"key":"36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/S1473-3099(21)00462-X","article-title":"Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years: a randomised, double-blind, controlled, phase 1\/2 trial.","volume":"2","author":"Huang","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"37","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S1473-3099(20)30987-7","article-title":"Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1\/2 clinical trial.","volume":"2","author":"Ding","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"38","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.3389\/fimmu.2017.01960","article-title":"Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes?","volume":"8","author":"Franceschi","year":"2018","journal-title":"Front Immunol"},{"key":"39","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/s0047-6374(98)00096-7","article-title":"Modification of HLA expression on peripheral lymphocytes and monocytes during aging.","volume":"10","author":"Drouet","year":"1998","journal-title":"Mech Ageing Dev"},{"key":"40","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/s41598-022-05788-6","article-title":"Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac).","volume":"1","author":"Ekanayake","year":"2022","journal-title":"Sci Rep"},{"key":"41","doi-asserted-by":"publisher","first-page":"100316","DOI":"10.1016\/j.lana.2022.100316","article-title":"Effectiveness of BBIBP-CorV, BNT162b2 and mRNA-1273 vaccines against hospitalisations among children and adolescents during the Omicron outbreak in Argentina: A retrospective cohort study.","volume":"1","author":"Kreplak","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"42","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3390\/vaccines10030389","article-title":"Early Effectiveness of Four SARS-CoV-2 Vaccines in Preventing COVID-19 among Adults Aged \u226560 Years in Vojvodina, Serbia.","volume":"1","author":"Risti\u0107","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"43","doi-asserted-by":"publisher","first-page":"100154","DOI":"10.1016\/j.lana.2021.100154","article-title":"Influence of age on the effectiveness and duration of protection of Vaxzevria and CoronaVac vaccines: A population-based study.","volume":"6","author":"Barral-Netto","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"44","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1080\/21645515.2020.1842683","article-title":"COVID-19 in the elderly people and advances in vaccination approaches.","volume":"1","author":"Malik","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"45","doi-asserted-by":"publisher","first-page":"100931","DOI":"10.1016\/j.blre.2022.100931","article-title":"COVID-19 breakthrough infections, hospitalizations and mortality in fully vaccinated patients with hematologic malignancies: A clarion call for maintaining mitigation and ramping-up research.","volume":"5","author":"Berger","year":"2022","journal-title":"Blood Rev"},{"key":"46","doi-asserted-by":"publisher","first-page":"e214302","DOI":"10.1001\/jamanetworkopen.2021.4302","article-title":"Association of Age With SARS-CoV-2 Antibody Response.","volume":"4","author":"Zhao","year":"2021","journal-title":"JAMA Netw Open"},{"key":"47","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1038\/s41418-020-0530-3","article-title":"COVID-19 infection: the perspectives on immune responses.","volume":"2","author":"Melino","year":"2020","journal-title":"Cell Death Differ"},{"key":"48","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1038\/s41366-020-0640-5","article-title":"Obesity, the most common comorbidity in SARS-CoV-2: is leptin the link?","volume":"4","author":"Greenway","year":"2020","journal-title":"Int J Obes (Lond)"},{"key":"49","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.4049\/jimmunol.0900562","article-title":"Inhibition of thymic adipogenesis by caloric restriction is coupled with reduction in age-related thymic involution.","volume":"18","author":"Dixit","year":"2009","journal-title":"J Immunol"},{"key":"50","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2174\/1573399815666191024085838","article-title":"Type 2 Diabetes and its Impact on the Immune System.","volume":"1","author":"Ruslami","year":"2020","journal-title":"Curr Diabetes Rev"},{"key":"51","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1016\/S0140-6736(21)02249-2","article-title":"Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.","volume":"39","author":"Balicer","year":"2021","journal-title":"Lancet"},{"key":"52","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/infdis\/jiab556","article-title":"Effectiveness of a Third Dose of BNT162b2 mRNA Vaccine.","volume":"22","author":"Ekka Zohar","year":"2022","journal-title":"J Infect Dis"},{"key":"53","doi-asserted-by":"publisher","first-page":"101455","DOI":"10.1016\/j.arr.2021.101455","article-title":"Underrepresentation of older adults in clinical trials on COVID-19 vaccines: A systematic review.","volume":"7","author":"Cherubini","year":"2021","journal-title":"Ageing Res Rev"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204299","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T16:18:08Z","timestamp":1664986688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,21]]},"references-count":53,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2022,9,29]]}},"alternative-id":["204299","36152043"],"URL":"https:\/\/doi.org\/10.18632\/aging.204299","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,21]]}}}